Book Value per Share: metaviatx.com (MTVA)
While robotic AI accelerates molecule discovery, the disciplined management of MetaVia Inc (MTVA) focuses on neurodegeneration therapy. This book value per share chart helps align these achievements with capital, where the 1.03 level represents the current value. However, the lack of sales due to its pre-commercial status makes the company's pricing potential dependent on future regulatory approvals.
MetaVia Inc. - analytical breakdowns and key metrics (MTVA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:metaviatx.com, MTVA
MetaVia Inc. investments in the development of dementia therapies in collaboration with neurological clinics require significant accumulation of tangible assets to support long-term research. The daily price action of the book value per share reflects the ratio of net equity to the number of securities, allowing investors to assess the business's intrinsic value and its resilience to drawdowns by analyzing the growth rates of its equity.
Competitor analysis for MetaVia Inc
BIIB - Accounting Value per Share|NBIX - Net Assets per Single Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share PRAX|Accounting Value per Share anavex.com|CeriBell - Book Value per Share|Net Asset Value per Share Prothena Corporation PRTA|Accounting Value per Share Alector (ALEC)|Book Price of a Share Annexon Biosciences Inc. ANNX|Omeros Corp. - Book Value per Share|neurogene.com (NGNE) - Book Value per Share|AC Immune SA (ACIU) - Accounting Value per Share|Voyager Therapeutics Inc (VYGR) - Net Assets per Single Share|NMRA: Book Value per Share|Net Assets per Share Scilex Holding Company, Inc.|Book Value per Share TVGN|Book Value per Share alphacognition.com ACOG|Accounting Value per Share Cognition Therapeutics|Accounting Value of a Share Inhibikase Therapeutics Inc IKT|Book Value per Share SAVA (Cassava)|ASRT: Net Assets per Share|Net Assets per Single Share coyatherapeutics.com|Vistagen (VTGN) - Equity per Share|Book Value per Share OVID|Accounting Value per Share ABOS|Net Assets per Single Share CRVO (CervoMed Inc)|Accounting Value per Share alteritytherapeutics.com ATHE|Accounting Value per Share Clene (CLNN)|PEPG - Book Price of a Share|JUNS - Accounting Value per Share|RLMD - Net Assets per Single Share|ANVS: Book Value per Share|GRCE (Grace Therapeutics) - Book Value per Share|Net Assets per Single Share Firefly Neuroscience, Inc (AIFF)|Equity per Share ANEW Medical, Inc.|NeuroSense Therapeutics - Book Value per Share|Net Asset Value per Share Reviva Pharmaceuticals Holdings Inc. RVPH|Accounting Value per Share NRXS (NeurAxis, Inc)|Helius Medical Technologies, Inc. - Book Value per Share|Net Assets per Single Share Passage Bio Corp (PASG)|NEUP: Accounting Value of a Share|Net Assets per Single Share NERV|ATHA (Athira Pharma Inc) - Net Asset Value per Share|Net Assets per Single Share ADXN|Accounting Value per Share Alzamend|Cyclerion Therapeutics - Book Value per Share|Net Asset Value per Share protagenic.com PTIX|Accounting Value per Share Pasithea Therapeutics Corp. (KTTA)|Book Price of a Share Cortigent Inc CRGT|Avenue Therapeutics, Inc - Book Value per Share|BrainStorm Cell Therapeutics Inc. (BCLI) - Book Value per Share|Cara Therapeutics, Inc. (CARA) - Accounting Value per Share|chromocell.com (CHRO) - Net Assets per Single Share|ELYM: Book Value per Share|Net Assets per Share Intra-Cellular|Book Value per Share LBPH|Book Value per Share Marinus Pharma MRNS|Accounting Value per Share NKGen Biotech, Inc.|Accounting Value of a Share neurobopharma.com NRBO|Book Value per Share SAGE (Sage Therapeutics)|SNPX: Net Assets per Share|Net Assets per Single Share Trevena, Inc|Vigil Neuroscience, Inc. (VIGL) - Equity per Share|Book Value per Share WENA|Accounting Value per Share CERE